A Study of DLX105-DMP in Subjects With Plaque Psoriasis

Key Inclusion Criteria:

Signed and dated informed consent.
Subjects aged 18-75 years.
Male subject, or if female, must be surgically sterile, post-menopausal, or using acceptable birth control.
Stable chronic mild-to-moderate plaque psoriasis.

Key Exclusion Criteria:

Non-plaque-type psoriasis only (e.g., pustular, erythrodermic and guttate psoriasis, palmar, or plantar) at Screening.
Drug-induced psoriasis (i.e., new onset or exacerbation from beta-blockers, calcium channel inhibitors or lithium) within 3 months prior to Day 1.
Ongoing use of psoriasis treatments or inadequate duration of washout prior to Day 1